Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study.

Rasmussen CB, Lindenberg S.

Front Endocrinol (Lausanne). 2014 Aug 27;5:140. doi: 10.3389/fendo.2014.00140. eCollection 2014.

2.

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin.

Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A.

Eur J Endocrinol. 2014 Feb 7;170(3):451-9. doi: 10.1530/EJE-13-0797. Print 2014 Mar.

3.
5.

Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.

Ferjan S, Janez A, Jensterle M.

Metab Syndr Relat Disord. 2017 Dec;15(10):515-520. doi: 10.1089/met.2017.0095. Epub 2017 Oct 24.

PMID:
29064743
6.

Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial.

Jensterle M, Kravos NA, Goričar K, Janez A.

BMC Endocr Disord. 2017 Jan 31;17(1):5. doi: 10.1186/s12902-017-0155-9.

7.

Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.

Jensterle M, Pirš B, Goričar K, Dolžan V, Janež A.

Eur J Clin Pharmacol. 2015 Jul;71(7):817-24. doi: 10.1007/s00228-015-1868-1. Epub 2015 May 21.

PMID:
25991051
8.

Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome.

Jensterle M, Kocjan T, Kravos NA, Pfeifer M, Janez A.

Endocr Res. 2015;40(3):133-8. doi: 10.3109/07435800.2014.966385. Epub 2014 Oct 20.

PMID:
25330463
9.

Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial.

Nylander M, Frøssing S, Clausen HV, Kistorp C, Faber J, Skouby SO.

Reprod Biomed Online. 2017 Jul;35(1):121-127. doi: 10.1016/j.rbmo.2017.03.023. Epub 2017 Apr 24.

PMID:
28479118
10.

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls.

Kahal H, Aburima A, Ungvari T, Rigby AS, Coady AM, Vince RV, Ajjan RA, Kilpatrick ES, Naseem KM, Atkin SL.

BMC Endocr Disord. 2015 Apr 2;15:14. doi: 10.1186/s12902-015-0005-6.

11.

Liraglutide: an injectable option for the management of obesity.

Clements JN, Shealy KM.

Ann Pharmacother. 2015 Aug;49(8):938-44. doi: 10.1177/1060028015586806. Epub 2015 May 18. Review.

PMID:
25986009
12.

Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease.

Kahal H, Abouda G, Rigby AS, Coady AM, Kilpatrick ES, Atkin SL.

Clin Endocrinol (Oxf). 2014 Oct;81(4):523-8. doi: 10.1111/cen.12369. Epub 2013 Dec 12.

PMID:
24256515
13.

Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.

Ujvari D, Hulchiy M, Calaby A, Nybacka Å, Byström B, Hirschberg AL.

Hum Reprod. 2014 Jul;29(7):1526-35. Epub 2014 May 19.

PMID:
24842895
14.

Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential.

Nylander M, Frøssing S, Kistorp C, Faber J, Skouby SO.

Endocr Connect. 2017 Feb;6(2):89-99. doi: 10.1530/EC-16-0113. Epub 2017 Jan 24.

15.

Pharmacologic therapy to induce weight loss in women who have obesity/overweight with polycystic ovary syndrome: a systematic review and network meta-analysis.

Wang FF, Wu Y, Zhu YH, Ding T, Batterham RL, Qu F, Hardiman PJ.

Obes Rev. 2018 Oct;19(10):1424-1445. doi: 10.1111/obr.12720. Epub 2018 Jul 31.

PMID:
30066361
17.

Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome.

Koiou E, Tziomalos K, Katsikis I, Kandaraki EA, Kalaitzakis E, Delkos D, Vosnakis C, Panidis D.

Gynecol Endocrinol. 2012 Jan;28(1):20-4. doi: 10.3109/09513590.2011.588745. Epub 2011 Jul 14.

PMID:
21756081
18.
19.

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.

Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjøth TV, Andreasen AH, Jensen CB, DeFronzo RA; NN8022-1922 Study Group.

JAMA. 2015 Aug 18;314(7):687-99. doi: 10.1001/jama.2015.9676. Erratum in: JAMA. 2016 Jan 5;315(1):90.

PMID:
26284720
20.

A retrospective study of the pregnancy, delivery and neonatal outcome in overweight versus normal weight women with polycystic ovary syndrome.

De Frène V, Vansteelandt S, T'Sjoen G, Gerris J, Somers S, Vercruysse L, De Sutter P.

Hum Reprod. 2014 Oct 10;29(10):2333-8. doi: 10.1093/humrep/deu154. Epub 2014 Jun 24.

PMID:
24963163

Supplemental Content

Support Center